Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the treatment of multiple sclerosis using personalised medicine.

The EU Horizon 2020 has kicked off the...

Researchers, using camels as an inspiration, have finally developed antibodies against a group of proteins known as metalloproteinases (MMPs), which are involved in the pathology of diseases that...

A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's,...

Investigation into voltage-operated calcium channels may contribute to the development of improved treatment options for patients with multiple sclerosis and other neurodegenerative diseases. MS...

The U.S. Food and Drug Administration (FDA) has extended its review of Roche's multiple sclerosis drug Ocrevus by three months to March 28, the Swiss drugmaker said recently.

Roche is...

A leak of a protein called haemoglobin from damaged red blood cells may be associated with brain shrinkage in multiple sclerosis.
This is the conclusion of a team from Imperial College...

Ibudilast (MN-166) has shown enough promise as a treatment for progressive multiple sclerosis that its U.S. phase 2b trial (NCT01982942) should continue, the U.S. National Institute of Health’s...

A drug that alters the immune system has been described as "big news" and a "landmark" in treating multiple sclerosis, doctors and charities say.

Trials, published in the New England...

Alterations in microorganisms in the brains of multiple sclerosis patients could contribute to underlying disease mechanisms, including demyelination, according to researchers.

The study, “...

Researchers at the University at Buffalo have identified a critical step in myelination after birth that has significance for treating neurodegenerative diseases like multiple sclerosis, in which...

Pages

Live Chat Software by Click4Assistance UK